Evidence map›Paper›PMID 37287985›Full record

ArticleFrontiers in immunology2023

Yuhua Chen, Junhui Chen, Hong Wei, Kai Gong, Jiao Meng, Tianlin Long, Jianfeng Guo, Jun Hong, Lingjian Yang, Junling Qiu and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. The Impact ofCurrent neuropharmacology · 2025
    Pooled it
  2. The role ofFrontiers in medicine · 2025
    Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Yuhua ChenDepartment of Anatomy and Neurobiology, School of Basic Medical Science, Central South University, Changsha, Hunan, China.
Junhui ChenDepartment of Anatomy and Neurobiology, School of Basic Medical Science, Central South University, Changsha, Hunan, China.
Hong WeiDepartment of Neurosurgery, Bijie Traditional Chinese Medical Hospital, Bijie, Guizhou, China.
Kai GongXiamen Key Laboratory of Brain Center, Department of Neurosurgery, Trauma Center, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China.
Jiao MengDepartment of Neurosurgery, Bijie Traditional Chinese Medical Hospital, Bijie, Guizhou, China.
Tianlin LongDepartment of Neurosurgery, Bijie Traditional Chinese Medical Hospital, Bijie, Guizhou, China.
Jianfeng GuoXiamen Key Laboratory of Brain Center, Department of Neurosurgery, Trauma Center, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China.
Jun HongDepartment of Anatomy and Neurobiology, School of Basic Medical Science, Central South University, Changsha, Hunan, China.
Lingjian YangSchool of Chemistry & Chemical Engineering, Ankang University, Ankang, China.
Junling QiuDepartment of Cardiology, First Hospital of Northwestern University, Shannxi, China.
Kun XiongDepartment of Anatomy and Neurobiology, School of Basic Medical Science, Central South University, Changsha, Hunan, China.
Zhanxiang WangXiamen Key Laboratory of Brain Center, Department of Neurosurgery, Trauma Center, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China.
Quanhua XuDepartment of Neurosurgery, Bijie Traditional Chinese Medical Hospital, Bijie, Guizhou, China.
Central South University · CNFirst Affiliated Hospital of Xiamen University · CNAnkang University · CNXi'an Peihua University · CNXi'an Siyuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Gut-microbiota-brain axis is a potential treatment to decrease the risk of chronic traumatic encephalopathy following traumatic brain injury (TBI). Phosphoglycerate mutase 5 (PGAM5), a mitochondrial serine/threonine protein phosphatase, resides in mitochondrial membrane and regulates mitochondrial homeostasis and metabolism. Mitochondria mediates intestinal barrier and gut microbiome. Objectives: This study investigated the association between PGAM5 and gut microbiota in mice with TBI. Methods: The controlled cortical impact injury was established in mice with genetically-ablated Results: Treated with antibiotics for suppressing gut microbiota in Conclusion: Thus, the present study provides evidence that Pgam5 is involved in gut microbiota-mediated neuroinflammation and nerve injury, with

Indexed as

Brain Injuries, TraumaticNeuroprotectionAkkermansiaAnimalsMaleMiceNeuroinflammatory DiseasesNLR Family, Pyrin Domain-Containing 3 ProteinPhosphoglycerate MutaseVerrucomicrobiaNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mousePhosphoglycerate MutaseAkkermansia muciniphilagut-microbiota-brain axisneuroprotectionNlrp3Pgam5TBI

Identifiers

PMID37287985
PMCPMC10242175
OpenAlexW4378085970

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.